Replacement of HLA class II serology by the HLA-DR microtitre plate oligotyping assay: a one-year experience in unrelated bone marrow donor selection.
Because the selection of unrelated bone marrow donors requires a more accurate HLA-typing technique than is used for sibling donors, we have replaced class II serology by a rapid and highly discriminative HLA-DR DNA oligotyping assay on microtitre plates. We present here our 1-year experience with class II typing for 112 potential donors identified for 33 consecutive leukaemic patients. Although the donors were selected to be HLA-A, -B, -DR serologically identical, the microtitre plate oligotyping assay detected DR incompatibilities in 52.7% of the patient/donor pairs. One third was due to incorrect or incomplete typing of DR11 to DR16, the others to mismatches for the serologically indistinguishable subtypes of DR1, 11, 13 and 15, known to be relevant for T cell recognition.
Tiercy
J M
JM
Transplantation Immunology Unit, Hôpital Cantonal of Geneva, Switzerland.
Roosnek
E
E
Speiser
D
D
Cros
P
P
Allibert
P
P
Mach
B
B
Jeannet
M
M
D016026:Bone Marrow Transplantation; D006681:HLA-D Antigens / Q000097:blood; D006684:HLA-DR Antigens / Q000032:analysis*; D006650:Histocompatibility Testing / Q000379:methods; D006801:Humans; D007938:Leukemia / Q000601:surgery; D016133:Polymerase Chain Reaction
D006681:HLA-D Antigens; D006684:HLA-DR Antigens